Brainstorm Cell Therapeutics - 53 Year Dividend History | BCLI

Historical dividend payout and yield for Brainstorm Cell Therapeutics (BCLI) since 1971. The current TTM dividend payout for Brainstorm Cell Therapeutics (BCLI) as of May 17, 2024 is $0.00. The current dividend yield for Brainstorm Cell Therapeutics as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.036B $0.000B
BrainStorm Cell Therapeutics Inc. is a biotechnology company. It develops autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Parkinson's disease. Brainstorm Cell Therapeutics is based in New York.
Stock Name Country Market Cap PE Ratio